Description

Thioctic Acid Injection is a sterile formulation containing 0.3g of alpha-lipoic acid per 12ml vial. Known for its antioxidant and neuroprotective properties, Thioctic Acid is widely studied in models of diabetic neuropathy, mitochondrial function, and oxidative stress.

This injectable-grade compound is designed for in-vitro or in-vivo preclinical research under controlled lab environments. Each box includes [1] vial for investigative use. Supplied by Jilin Changlong Biochemical Pharmaceutical Co., Ltd.

Product Specifications

• Product Name: Thioctic Acid Injection

• Synonym: Alpha-Lipoic Acid, Lipoate

• Formulation: Injectable solution

• Strength: 0.3g/12ml

• CAS Number: 1077-28-7

• Molecular Formula: C8H14O2S2

• Molecular Weight: 206.33 g/mol

• Package Size: 1 vial per box

• Drug Approval Number: H20243561 (China NMPA)

• Manufacturer: Jilin Changlong Biopharmaceutical Co., Ltd.

• National Drug Code (CN): 86903421002410

Mechanism of Action

Thioctic Acid acts as a mitochondrial coenzyme involved in oxidative metabolism. It exhibits potent antioxidant activity, facilitates glucose uptake, regenerates endogenous antioxidants (e.g., glutathione), and may play a role in mitochondrial energy production.

Side Effects (Literature-based)

In clinical contexts, alpha-lipoic acid may cause:

• Nausea or stomach upset

• Rash or itching

• Headache

• Lowered blood glucose

• Injection-site irritation

For research use only. These effects are cited from clinical/animal models and do not imply any use in humans.

Disclaimer

This product is strictly for laboratory research use only. It is not intended for human consumption or therapeutic use. Researchers must handle with appropriate safety procedures under applicable laws and institutional guidelines.